Q4 2025 earnings call recap: revenue growth, 2026 guidance, Category 1 CPT impact, and BENEFIT-HF trial upside—read key takeaways.

Sensus Healthcare (NASDAQ:SRTS) used its fourth-quarter and full-year 2025 earnings call to emphasize a major regulatory and ...

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological ...

Adjusted operating margin is projected in the range of 6% to 8%, with net income per diluted share in the range of $1.23 to $1.81 and adjusted net income per diluted share in the range of $1.85 to ...

MINNEAPOLIS - Inspire Medical Systems, Inc. (NYSE:INSP) reported fourth quarter earnings that beat analyst expectations, but shares tumbled 8.7% as the company disclosed a coding clarification that ...

Medical billing and coding systems ensure that health providers get paid for their services. Learn the steps in medical billing and medical coding.

Compensation and reimbursement plans vary widely across the healthcare system. Collections-based, dollar per relative value unit (RVU) or salary plus incentive are three of the most commonly used ...

Fourth quarter revenue growth of 12% and full year revenue growth of 14%Fourth quarter net income per diluted share of $4.66; adjusted net income ...

Revenue generated in the U.S. was $51.9 million for the year ended December 31, 2025, an increase of $4.7 million, or 10%, over the year ended December 31, 2024. Revenue units in the U.S. totaled ...

Inspire Medical Systems, Inc. (NYSE:INSP) Q4 2025 Earnings Call Transcript February 11, 2026 Inspire Medical Systems, Inc.

SRT: Superficial Radiation Therapy, a low-energy radiation-based technology used for noninvasive skin cancer treatment. IGSRT ...

Artivion, Inc. , a leading cardiac and vascular surgery company focused on aortic disease, today announced financial results for the fourth quarter and year ended December 31, ...